KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Jae Cheol Lee

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 17건 중 1-17 번을 표시중입니다.

1 Article A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer Eo Jin Kim ; Yong-Hee Cho ; Dong Ha Kim ; et al 2022
2 Article AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8+ T cells by inducing CD103+ dendritic cell-mediated T cell priming Kyungtaek Im ; Yun Jung Choi ; Dong Ha Kim ; et al 2023
3 Article CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer Yunha Nam ; Chang-Min Choi ; Young Soo Park ; et al 2022
4 Article Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis Sora Kang ; Hyehyun Jeong ; Ji Eun Park ; et al 2023
5 Article Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single‐center, retrospective cohort study Dong‐gon Hyun ; Soo Jin Han ; Wonjun Ji ; et al 2023
6 Article Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy Jaewon Hyung ; Hyunseok Yoon ; Chang-Min Choi ; et al 2023
7 Article Generation of genetically engineered mice for lung cancer with mutant EGFR Da-Som Kim ; Wonjun Ji ; Dong Ha Kim ; et al 2022
8 Article Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer Dong Ha Kim ; Hyojeong Park ; Yun Jung Choi ; et al 2023
9 Article Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment Myeong Geun Choi ; Chang-Min Choi ; Dae Ho Lee ; et al 2022
10 Article Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer Changhwan Sung ; Jinhyeon An ; Soohyeon Lee ; et al 2023
11 Article Nivolumab as maintenance therapy following platinum-based chemotherapy in EGFR-mutant lung cancer patients after tyrosine kinase inhibitor failure: A single-arm, open-label, phase 2 trial Jiwon Kim ; Chang-Min Choi ; Wonjun Ji ; et al 2023
12 Article Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment Yoon Jung Jang ; Dong-Gon Hyun ; Wonjun Ji ; et al 2023
13 Article Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer Jang Ho Lee ; Eun Young Kim ; Cheol-Kyu Park ; et al 2023
14 Article Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean population Da Som Jeon ; Jin Woo Kim ; Seul Gi Kim ; et al 2022
15 Article Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database Min-Hyung Kim ; Sojung Park ; Yu Rang Park ; et al 2023
16 Article The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study Jwa Hoon Kim ; Seyoung Seo ; Jee Hyun Kim ; et al 2022
17 Article Two-year efficacy of SNK01 plus pembrolizumab for non-small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial Hyung Jun Park ; Yong Man Kim ; Jae Seob Jung ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.